Cover Image
市場調查報告書

全球胰島素市場未來展望

Global Insulin Market Outlook 2018

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 299596
出版日期 內容資訊 英文 55 Pages
訂單完成後即時交付
價格
Back to Top
全球胰島素市場未來展望 Global Insulin Market Outlook 2018
出版日期: 2014年04月01日 內容資訊: 英文 55 Pages
簡介

2013年全球整體有3億8100萬人為糖尿病所苦,到2035年將擴大為5億9100萬人。隨著糖尿病患者的劇增,胰島素產品的需求也急速擴大。胰島素療法作為I型糖尿病的標準治療方法而普及。由於糖尿病患者數增加及漸進性,全球胰島素市場,預計2012∼2018年以年複合成長率10%以上的速度成長。

本報告提供全球的胰島素市場最新趨勢與未來展望相關分析、糖尿病的發病與患病情形,及近幾年治療方法的開發與普及情形、今後的市場趨勢預測(今後5年份)、主要國家市場(印度、中國、美國、俄羅斯等)的詳細趨勢、重量級產品的專利失效狀況,再加上主要企業簡介(產業概要、產品結構、市場佔有率等)、今後的市場方向性等調查,並將結果概述為以下內容。

第1章 分析師的見解

第2章 分析方法

第3章 全球蛋白質療法市場

  • 蛋白質療法市場與醫藥品市場
  • 現在、未來市場分析
    • 市場分類

第4章 胰島素市場未來展望

  • 科學性考察
  • 現在、未來市場分析
  • 主要企業與藥物
  • 各類型分析
    • 作用機制
    • 合成機制
  • 各用途分析
    • 各地區分析
  • 主要國家市場
    • 印度
    • 中國
    • 美國
    • 俄羅斯
    • 日本
    • 巴西

第5章 胰島素的專利失效情形

第6章 主要企業

  • Sanofi-Aventis
  • Novo Nordisk
  • Eli Lilly. Company
  • Wockhardt
  • Biocon

圖表一覽

目錄

About 381 Million people suffered from diabetes in 2013 globally, which is likely to reach 591 Million by 2035. The growing number of diabetes patients at such a high pace significantly increases the demand for insulin products. The discovery of Insulin therapy has remained as a standard treatment for both Type I diabetes. Owing to the growing prevalence of diabetes and progressive nature of the disease, the global insulin market is forecasted to grow at a CAGR of over 10% during 2012-2018.

Our RNCOS research report, “Global Insulin Market Outlook 2018”, has revealed that the Insulin market has witnessed huge growth prospects based on these novel insulin delivery device systems. Recent advancements in administration of insulin include inhalable insulin, topical patches, spray insulin and painless insulin pens/pumps. Our comprehensive research work also studies how patent expiry of block buster insulin products would create opportunities for biosimilars.

The report conducts an in-depth analysis of diabetic patient population across leading geographies including India, China, US, Russia, etc. to understand the structure of the insulin market in these countries. The report covers insulin market break up by mode of action and synthesis. Our extensive study looks into the competitive landscape key players in the insulin market covering business overview, product portfolio, market share and company level activities. Overall, the research aims at presenting a balanced picture of the global insulin market to the clients.

Table of Contents

1. Analyst View

2. Research Methodology

3. Global Protein Therapeutics Market

  • 3.1. Protein Therapeutics Market vs Pharmaceutical Market
  • 3.2. Current and Future Market Analysis to 2018
    • 3.2.1. Market Segmentation

4. Insulin Market Forecast to 2018

  • 4.1. Scientific Insight
  • 4.2. Current and Future Market Analysis to 2018
  • 4.3. Key Players and Drugs
  • 4.4. By Type of Insulin
    • 4.4.1. Mode of Action
    • 4.4.2. Mode of Synthesis
  • 4.5. By Application
    • 4.5.1. Regional Analysis
  • 4.6. Key Geographical Markets
    • 4.6.1. India
    • 4.6.2. China
    • 4.6.3. US
    • 4.6.4. Russia
    • 4.6.5. Japan
    • 4.6.6. Brazil

5. Patent Expiry Status of Insulin

6. Key Players

  • 6.1. Sanofi-Aventis
  • 6.2. Novo Nordisk
  • 6.3. Eli Lilly. Company
  • 6.4. Wockhardt
  • 6.5. Biocon

List of Figures:

  • Figure 3-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2013
  • Figure 3-2: Global - Protein Therapeutics Market (Billion US$), 2013-2018
  • Figure 3-3: Global - Protein Therapeutics Market by Segment (%), 2013
  • Figure 3-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2018
  • Figure 4-1: Global - Insulin Market (Billion US$), 2013-2018
  • Figure 4-2: Global - Share of Key Players in Insulin Market (2013)
  • Figure 4-3: Global - Share of Products in Insulin Market (2013)
  • Figure 4-4: Insulin Market by Mode of Action (%), 2013
  • Figure 4-5: Insulin Market by Mode of Action (%), 2018
  • Figure 4-6: Insulin Market by Mode of Synthesis (%), 2013
  • Figure 4-7: Insulin Market by Mode of Synthesis (%), 2018
  • Figure 4-8: Global - Number of Diabetic Patients (Million), 2013 & 2035
  • Figure 4-9: Diabetes Prevalence by Region (%), 2013
  • Figure 4-10: Diabetes Prevalence by Region (%), 2035
  • Figure 4-11: India - Insulin Market (Million US$), 2013-2018
  • Figure 4-12: China - Insulin Market (Billion US$), 2013-2018
  • Figure 4-13: US - Insulin Market (Billion US$), 2013-2018
  • Figure 4-14: Russia - Insulin Market (Million US$), 2013-2018
  • Figure 4-15: Japan - Insulin Market (Billion US$), 2013-2018
  • Figure 4-16: Brazil - Insulin Market (Million US$), 2013-2018

List of Tables:

  • Table 4-1: Key Insulin Product Sales (Billion US$), 2010-2013
  • Table 4-2: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
  • Table 4-3: China - Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
  • Table 4-4: US - Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
  • Table 4-5: Russia - Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
  • Table 4-6: Japan - Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
  • Table 4-7: Brazil - Diabetic Patients in Age Group 20-79 Years (‘000), 2013 & 2035
  • Table 5-1: Global - Patent Expiry Status of Key Insulin Products
  • Table 6-1: Sanofi-Aventis - Insulin Products
  • Table 6-2: Novo Nordisk - Insulin Products
  • Table 6-3: Eli Lilly - Insulin Products
  • Table 6-4: Wockhardt - Insulin Products
  • Table 6-5: Biocon - Insulin Products
Back to Top